Learn About Iridogoniodysgenesis Type 1

What is the definition of Iridogoniodysgenesis Type 1?
Iridogoniodysgenesis type 1 is a rare condition that affects the eyes. People with this condition are born with malformations of the iris (the colored part of the eye) and cornea, which eventually lead to early-onset glaucoma. The irides of affected people are unusually dark. For example, studies of the condition often describe 'brown' irides as a dark, chocolate color and 'blue' irides as a very dark, slate gray. The iris also lacks the usual pattern and has a smooth appearance. Iridogoniodysgenesis type 1 is caused by changes (mutations) in the FOXC1 gene and is inherited in an autosomal dominant manner. Management is based on the signs and symptoms present in each person and is generally focused on the screening and eventual treatment of glaucoma.
Save information for later
Sign Up
What are the alternative names for Iridogoniodysgenesis Type 1?
  • Iridogoniodysgenesis anomaly, Autosomal dominant
  • IRID1
  • IGDA
  • IGDA syndrome
Who are the top Iridogoniodysgenesis Type 1 Local Doctors?
Distinguished
Highly rated in
5
conditions

Radboud University Medical Center

Amsterdam, NH, NL 

Shazia Micheal is in Amsterdam, Netherlands. Micheal is rated as a Distinguished expert by MediFind in the treatment of Iridogoniodysgenesis Type 1. She is also highly rated in 5 other conditions, according to our data. Her top areas of expertise are Brittle Cornea Syndrome, Iridogoniodysgenesis Type 1, Axenfeld-Rieger Syndrome, and Glaucoma.

Distinguished
Highly rated in
6
conditions

University Of Alberta

Edmonton, AB, CA 

Michael Walter is in Edmonton, Canada. Walter is rated as a Distinguished expert by MediFind in the treatment of Iridogoniodysgenesis Type 1. He is also highly rated in 6 other conditions, according to our data. His top areas of expertise are Axenfeld-Rieger Syndrome, Iridogoniodysgenesis Type 1, Fish-Eye Disease, and Peters Anomaly.

 
 
 
 
Learn about our expert tiers
Learn more
Distinguished
Highly rated in
2
conditions

University Of Alberta

Edmonton, AB, CA 

Morteza Seifi is in Edmonton, Canada. Seifi is rated as a Distinguished expert by MediFind in the treatment of Iridogoniodysgenesis Type 1. They are also highly rated in 2 other conditions, according to our data. Their top areas of expertise are Axenfeld-Rieger Syndrome, Iridogoniodysgenesis Type 1, Hearing Loss, and Status Epilepticus.

What are the latest Iridogoniodysgenesis Type 1 Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
What are the Latest Advances for Iridogoniodysgenesis Type 1?
Surgical outcomes of Glaucoma associated with Axenfeld-Rieger syndrome.
The diagnosis and phacoemulsification in combination with intraocular lens implantation for an Axenfeld-Rieger syndrome patient with small cornea: a case report.
Tired of the same old research?
Check Latest Advances
Improvement of Open Bite and Stomatognathic Function in an Axenfeld- Rieger Syndrome Patient by Orthodontic Sectional Arch Mechanics: Clinical Considerations and the Risk of Orthodontic Tooth Movement.